Last data update: May 13, 2024 . (Total: 1930 publications since 2020)
Records 1-17 (of 17 Records) |
Query Trace: McLean C[original query] |
---|
COVID-19 Stats: COVID-19 Incidence,* by Age Group
Duca LM , Xu L , Price SF , McLean CA . MMWR Morb Mortal Wkly Rep 2021 69 (5152) 1664 |
COVID-19 Stats: COVID-19 Incidence,* by Urban-Rural Classification
Duca LM , Coyle J , McCabe C , McLean CA . MMWR Morb Mortal Wkly Rep 2020 69 (46) 1753 |
Effectiveness of first and second COVID-19 mRNA vaccine monovalent booster doses during a period of circulation of Omicron variant sublineages: December 2021-July 2022.
Petrie JG , King JP , McClure DL , Rolfes MA , Meece JK , Pattinson D , Neumann G , Kawaoka Y , Belongia EA , McLean HQ . Influenza Other Respir Viruses 2023 17 (3) e13104 |
Comparison of COVID-19 pandemic waves in 10 countries in Southern Africa, 2020-2021
Smith-Sreen J , Miller B , Kabaghe AN , Kim E , Wadonda-Kabondo N , Frawley A , Labuda S , Manuel E , Frietas H , Mwale AC , Segolodi T , Harvey P , Seitio-Kgokgwe O , Vergara AE , Gudo ES , Dziuban EJ , Shoopala N , Hines JZ , Agolory S , Kapina M , Sinyange N , Melchior M , Mirkovic K , Mahomva A , Modhi S , Salyer S , Azman AS , McLean C , Riek LP , Asiimwe F , Adler M , Mazibuko S , Okello V , Auld AF . Emerg Infect Dis 2022 28 (13) S93-s104 |
Public Willingness to Engage With COVID-19 Contact Tracing, Quarantine, and Exposure Notification.
Liccardi I , Alekseyev J , Woltz VLA , McLean JE , Zurko ME . Public Health Rep 2022 137 333549221125891 |
Innovative Approaches to COVID-19 Case Investigation and Contact Tracing.
Haddad MB , McLean JE , Feldman SS , Sizemore EE , Taylor MM . Public Health Rep 2022 137 333549221120454 |
Digital Tools Adopted by Public Health Agencies to Support COVID-19 Case Investigation and Contact Tracing, United States, 2020-2021.
Surio P , McLean JE , Jain A , Chughtai Z , Ruebush E , Lane JT , Ali H , Pina J . Public Health Rep 2022 137 333549221116136 |
Effectiveness of two and three mRNA COVID-19 vaccine doses against Omicron- and Delta-Related outpatient illness among adults, October 2021-February 2022.
Kim SS , Chung JR , Talbot HK , Grijalva CG , Wernli KJ , Kiniry E , Martin ET , Monto AS , Belongia EA , McLean HQ , Gaglani M , Mamawala M , Nowalk MP , Moehling Geffel K , Tartof SY , Florea A , Lee JS , Tenforde MW , Patel MM , Flannery B , Bentz ML , Burgin A , Burroughs M , Davis ML , Howard D , Lacek K , Madden JC , Nobles S , Padilla J , Sheth M . Influenza Other Respir Viruses 2022 16 (6) 975-985 |
SARS-CoV-2 virus dynamics in recently infected people - data from a household transmission study.
Mellis AM , Meece JK , Halasa NB , Chappell JD , McLean HQ , Grijalva CG , Hanson KE , Zhu Y , Kim A , Deyoe J , Ivacic LC , Reed C , Talbot HK , Rolfes MA . J Infect Dis 2022 226 (10) 1699-1703 |
mRNA COVID-19 vaccine effectiveness against SARS-CoV-2 infection in a prospective community cohort, rural Wisconsin, November 2020 to December 2021.
McLean HQ , McClure DL , King JP , Meece JK , Pattinson D , Neumann G , Kawaoka Y , Rolfes MA , Belongia EA . Influenza Other Respir Viruses 2022 16 (4) 607-612 |
Household Transmission and Clinical Features of SARS-CoV-2 Infections.
McLean HQ , Grijalva CG , Hanson KE , Zhu Y , Deyoe JE , Meece JK , Halasa NB , Chappell JD , Mellis AM , Reed C , Belongia EA , Talbot HK , Rolfes MA . Pediatrics 2022 149 (3) |
Vaccine effectiveness against COVID-19 among symptomatic persons aged ≥12 years with reported contact with COVID-19 cases, February-September 2021.
Chung JR , Kim SS , Belongia EA , McLean HQ , King JP , Nowalk MP , Zimmerman RK , Moehling Geffel K , Martin ET , Monto AS , Lamerato LE , Gaglani M , Hoffman E , Volz M , Jackson ML , Jackson LA , Patel MM , Flannery B . Influenza Other Respir Viruses 2022 16 (4) 673-679 |
mRNA Vaccine Effectiveness against COVID-19 among Symptomatic Outpatients Aged ≥16 Years in the United States, February - May 2021.
Kim SS , Chung JR , Belongia EA , McLean HQ , King JP , Nowalk MP , Zimmerman RK , Balasubramani GK , Martin ET , Monto AS , Lamerato LE , Gaglani M , Smith ME , Dunnigan KM , Jackson ML , Jackson LA , Tenforde MW , Verani JR , Kobayashi M , Schrag S , Patel MM , Flannery B . J Infect Dis 2021 224 (10) 1694-1698 |
Real-Time CDC Consultation during the COVID-19 Pandemic-United States, March-July, 2020.
Wozniczka D , Demeke HB , Thompson-Paul AM , Ijeoma U , Williams TR , Taylor AW , Tan KR , Chevalier MS , Agyemang E , Dowell D , Oduyebo T , Shiferaw M , Coleman King SM , Minta AA , Shealy K , Oliver SE , McLean C , Glover M , Iskander J . Int J Environ Res Public Health 2021 18 (14) |
Implications of Shortened Quarantine Among Household Contacts of Index Patients with Confirmed SARS-CoV-2 Infection - Tennessee and Wisconsin, April-September 2020.
Rolfes MA , Grijalva CG , Zhu Y , McLean HQ , Hanson KE , Belongia EA , Halasa NB , Kim A , Meece J , Reed C , Talbot HK , Fry AM . MMWR Morb Mortal Wkly Rep 2021 69 (5152) 1633-1637 |
Transmission of SARS-COV-2 Infections in Households - Tennessee and Wisconsin, April-September 2020.
Grijalva CG , Rolfes MA , Zhu Y , McLean HQ , Hanson KE , Belongia EA , Halasa NB , Kim A , Reed C , Fry AM , Talbot HK . MMWR Morb Mortal Wkly Rep 2020 69 (44) 1631-1634 |
Rapid Adaptation of HIV Treatment Programs in Response to COVID-19 - Namibia, 2020.
Hong SY , Ashipala LSN , Bikinesi L , Hamunime N , Kamangu JWN , Boylan A , Sithole E , Pietersen IC , Mutandi G , McLean C , Dziuban EJ . MMWR Morb Mortal Wkly Rep 2020 69 (42) 1549-1551 |
- Page last reviewed:Feb 1, 2024
- Page last updated:May 13, 2024
- Content source:
- Powered by CDC PHGKB Infrastructure